Transforming growth factor
2 induced pleurodesis
is not inhibited by corticosteroids
Y C G Leea b, C J Devina, L R Teixeirac, J T Rogersa, P J Thompsonb, K B Lanea, R W Lighta
a Departments of
Pulmonary Medicine, St Thomas Hospital and Vanderbilt University,
Nashville, Tennessee, USA, b Department of Medicine, University of Western
Australia, Perth, Australia, c Division of Respiratory Diseases, Heart
Institute (InCor), University of São Paulo Medical School,
São Paulo, Brazil
Correspondence to: Dr Y C G Lee , Department of Pulmonary Medicine, St Thomas Hospital, 4220 Harding Road, Nashville, TN 37202, USA ycgarylee{at}hotmail.com
Received 6 September 2000; Returned to authors 18 December 2000; Revised version received 24 January 2001; Accepted for publication 9 May 2001
BACKGROUND
Talc
and tetracyclines induce pleurodesis by directly injuring the
pleura. The injury results in intense inflammation which subsequently
leads to fibrosis. Corticosteroids can inhibit talc pleurodesis by
reducing the inflammatory process. We hypothesised that transforming
growth factor
2 (TGF
2), a fibrogenic
cytokine with immunomodulatory functions, could induce effective
pleurodesis without generating significant pleural inflammation and
therefore remain effective despite co-administration of corticosteroids.
METHODS
Thirty rabbits
were divided into two groups. Rabbits in the steroid group received
weekly intramuscular injections of triamcinolone diacetate
(0.8 mg/kg). Ten rabbits in each group were given 5.0 µg
TGF
2 intrapleurally via a chest tube while the remaining
five received 1.7 µg TGF
2. Pleurodesis was graded
macroscopically after 14 days from 1 (none) to 8 (>50% symphysis).
RESULTS
TGF
2
produced excellent pleurodesis at both 5.0 µg and 1.7 µg doses.
The pleural effusions produced after the injection were low in all
inflammatory markers. No significant differences were seen between the
steroid group and controls in macroscopic pleurodesis scores (7.2 (1.3)
v 7.1 (1.2)), levels of inflammatory markers in the pleural fluids (leucocyte 1107 (387)/mm3
v 1376 (581)/mm3; protein 3.1 (0.3) mg/dl v 2.9 (0.3) mg/dl, and LDH 478 (232) IU/l v 502 (123) IU/l), and the
degree of microscopic pleural fibrosis and pleural inflammation.
CONCLUSIONS
TGF
2
can induce effective pleurodesis and remains effective in the presence
of high dose parenteral corticosteroids.
Keywords: transforming growth factor
;
pleurodesis;
corticosteroids;
pleural effusion
© 2001 by Thorax
This article has been cited by other articles:
-
Decologne, N., Kolb, M., Margetts, P. J., Menetrier, F., Artur, Y., Garrido, C., Gauldie, J., Camus, P., Bonniaud, P.
(2007). TGF-beta1 Induces Progressive Pleural Scarring and Subpleural Fibrosis. J. Immunol.
179: 6043-6051
[Abstract] [Full Text] -
Teixeira, L. R., Vargas, F. S., Acencio, M. M. P., Paz, P. F. S., Antonangelo, L., Vaz, M. A. C., Marchi, E.
(2005). Influence of Antiinflammatory Drugs (Methylprednisolone and Diclofenac Sodium) on Experimental Pleurodesis Induced by Silver Nitrate or Talc. Chest
128: 4041-4045
[Abstract] [Full Text] -
Dikensoy, O., Zhu, Z., Donnelly, E., Stathopoulos, G. T., Lane, K. B., Light, R. W.
(2005). Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits. Chest
128: 3735-3742
[Abstract] [Full Text] -
Guo, Y. B., Kalomenidis, I., Hawthorne, M., Parman, K. S., Lane, K. B., Light, R. W.
(2005). Pleurodesis Is Inhibited by Anti-Vascular Endothelial Growth Factor Antibody. Chest
128: 1790-1797
[Abstract] [Full Text] -
Allen, S. S., Cassone, L., Lasco, T. M., McMurray, D. N.
(2004). Effect of Neutralizing Transforming Growth Factor {beta}1 on the Immune Response against Mycobacterium tuberculosis in Guinea Pigs. Infect. Immun.
72: 1358-1363
[Abstract] [Full Text] -
Lee, Y.C.G., Lane, K.B., Zoia, O., Thompson, P.J., Light, R.W., Blackwell, T.S.
(2003). Transforming growth factor-{beta} induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur Respir J
22: 197-202
[Abstract] [Full Text] -
LEE, Y. C. G., MELKERNEKER, D., THOMPSON, P. J., LIGHT, R. W., LANE, K. B.
(2002). Transforming Growth Factor beta Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro. Am. J. Respir. Crit. Care Med.
165: 88-94
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
